Cite
APA Citation
Jacobsen, E., Ďuraš, J., Ardeshna, K., Cherry, M., Offner, F., Mayer, J., Bijou, F., Tani, M., Musuraca, G., Merli, M., Marasca, R., Weaver, D., Lustgarten, S., Youssoufian, H., & Zinzani, P. (n.d.). cHARACTERIZATION OF DUVELISIB IN PATIENTS WITH REFRACTORY MARGINAL ZONE LYMPHOMA: DATA FROM THE PHASE 2 DYNAMO TRIAL. Hematological oncology, 37, 400–401. http://access.bl.uk/ark:/81055/vdc_100086192883.0x000045